KAZIA THERAPEUTICS LTD SPONSORED ADRKZIA made double bottom with divergence with good volume and breakout at $4.45 with first target of $22.5, if and second target of $41.7 and with can expect strong resistance at $41.7 and reverse might happen. If KZIA did breakout at this level we can expect rally till $79.
Analysis is made on week
Kazia Therapeutics Limited
No trades
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−12.31 USD
−13.41 M USD
27.20 K USD
About Kazia Therapeutics Limited
Sector
Industry
CEO
John E. Friend
Website
Headquarters
Sydney
Founded
1994
Identifiers
3
ISIN US48669G3039
Kazia Therapeutics Ltd. is an oncology-focused biotechnology company, which engages in the business of pharmaceutical drug development. It focuses on its Paxalisib program, which is designed to treat brain cancer. The company was founded by Graham Edmund Kelly in March 1994 and is headquartered in Sydney, Australia.
Related stocks
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
